Kazunari Yokoyama | Drug Discovery and Development | Best Scholar Award

Published on by Top Pharmaceutical

Prof. Dr. Kazunari Yokoyama | Drug Discovery and Development | Best Scholar Award

Kaohsiung Medical University | Taiwan

Prof. Dr. Kazunari Yokoyama is a distinguished molecular biochemist and genetic researcher whose academic journey reflects a deep and sustained commitment to biochemical, biophysical, and pharmaceutical sciences. He began his formal education in agricultural chemistry at Shizuoka University, where he developed a strong foundation in chemical and biological sciences that would later define his interdisciplinary research career. He advanced his graduate studies at The University of Tokyo, specializing in biochemical and biophysical chemistry, an environment that fostered his early interest in molecular mechanisms underlying biological systems. His doctoral training, carried out within the Department of Science at The University of Tokyo, was closely integrated with pharmaceutical sciences, benefiting from cross-divisional mentorship that enriched his scientific perspective.Prof. Yokoyama’s professional development was shaped by rigorous pre-doctoral and doctoral research training under renowned scientists in Japan, where he refined his expertise in experimental biochemistry, molecular biology, and immunological research. Following the completion of his doctoral studies, he expanded his international research experience through advanced postgraduate training in the United States. His postdoctoral fellowship in microbiology and immunology provided him with extensive exposure to immune system regulation at the molecular level, further strengthening his translational research capabilities. He subsequently held research and junior faculty positions in leading molecular genetics institutes, where he contributed to pioneering work in gene regulation, molecular genetics, and genome-related research.Upon returning to Japan, Prof. Yokoyama played an integral role in nationally significant research programs, including large-scale gene bank initiatives and collaborative genome projects. His work at prominent research centers emphasized chromosome biology, molecular regulation, aging, and genetic resource development. Through numerous collaborative appointments, both domestic and international, he established himself as a versatile and highly respected scientist whose career bridges basic biochemical research and large-scale genomic science. His scholarly contributions continue to influence molecular genetics, biochemical research infrastructure, and interdisciplinary life science innovation.

Citation Metrics (Scopus)

9000
6000
3000
1000
0

Citations
8,163

Documents
240

h-index
52


View Scopus Profile

Featured Publications

Xiangxuan Zhao | Drug Discovery and Development | Best Researcher Award

Published on by Top Pharmaceutical

Prof. Xiangxuan Zhao | Drug Discovery and Development | Best Researcher Award

Liaoning University of Traditional Chinese Medicine | China

Prof. Xiangxuan Zhao is a distinguished cell biologist and an eminent academic leader renowned for his pioneering contributions to the field of natural medicine-derived anti-cancer therapeutics. Serving as Professor, Doctoral Supervisor, and Postdoctoral Mentor, he holds prestigious positions as the Dean of the College of Laboratory Animal Medicine and Director of the Laboratory Animal Center at the Liaoning University of Traditional Chinese Medicine in Shenyang, China. With a career dedicated to advancing the frontiers of cancer biology and pharmaceutical innovation, Prof. Zhao has established himself as a leading authority in tumor drug resistance mechanisms, molecular target discovery, molecular targeted drug development, and tumor immunotherapy research.Prof. Zhao’s academic journey reflects a blend of scientific rigor and innovative leadership. Prior to his current roles, he contributed significantly as Deputy Director of the Engineering Technology Center for TCM Innovation at Liaoning University of Traditional Chinese Medicine and as a Researcher at the Health Science Research Institute of China Medical University. His earlier tenure as an Associate Researcher at Shengjing Hospital, China Medical University, laid the groundwork for his expertise in translational medicine, fostering a seamless bridge between laboratory research and clinical applications.A prolific scholar, Prof. Zhao has authored and co-authored eighty-four academic papers, including thirty-one SCI-indexed publications with a cumulative impact factor of one hundred eighty-eight. Among these, five papers boast impact factors exceeding ten, with his highest-impact publication reaching an impressive twenty-seven point four. His scientific excellence is further reflected in the thirteen national patents he holds, with four as the first inventor, underscoring his role as a trailblazer in molecular oncology and therapeutic innovation.

Profile: Orcid

Featured Publications

Liu, Y., Guo, R., Xue, C., Zhang, X., Xiao, F., Zhao, X., Zhu, Z., & Li, K. (2025). Phytosphingosine suppresses gastric cancer through SFRP4/β-catenin axis-mediated Wnt signaling pathway inhibition. Chemico-Biological Interactions.

Ke, W., Wang, H., Zhao, X., & Lu, Z. (2021). Foeniculum vulgare seed extract exerts anti-cancer effects on hepatocellular carcinoma. Food & Function.

Sun, W., Ren, Y., Lu, Z., & Zhao, X. (2020). The potential roles of exosomes in pancreatic cancer initiation and metastasis. Molecular Cancer.

Ke, W., Zhao, X., & Lu, Z. (2020). Bcl-2 is essential for Foeniculum vulgare seed extract-induced apoptosis in lung cancer. Research Square.